Elizabeth Arden, Inc. (RDEN) Tops Q2 EPS by 3c, Offers Q3 Outlook and Reaffirms FY12
Tweet Send to a FriendGet Alerts RDEN Hot Sheet
Price: $48.40 -0.82%
Revenue Growth %: +10.5%
Financial Fact:
Total cost of goods sold: 138.3M
Today's EPS Names:
BORN, EFUT, ZOOM, More
Revenue Growth %: +10.5%
Financial Fact:
Total cost of goods sold: 138.3M
Today's EPS Names:
BORN, EFUT, ZOOM, More
Trade RDEN Now!
Elizabeth Arden, Inc. (NASDAQ: RDEN) reported Q2 EPS of $1.42, $0.03 better than the analyst estimate of $1.39. Revenue for the quarter came in at $429.9 million versus the consensus estimate of $428.89 million.
Elizabeth Arden, Inc. reaffirmed FY2012 guidance.
Elizabeth Arden, Inc. sees Q3 2012 EPS of $0.00-$0.04, versus the consensus of $0.06. Elizabeth Arden, Inc. sees Q3 2012 revenue of $238-$243 million, versus the consensus of $243.45 million.
For earnings history and earnings-related data on Elizabeth Arden, Inc. (RDEN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Elizabeth Arden, Inc. reaffirmed FY2012 guidance.
Elizabeth Arden, Inc. sees Q3 2012 EPS of $0.00-$0.04, versus the consensus of $0.06. Elizabeth Arden, Inc. sees Q3 2012 revenue of $238-$243 million, versus the consensus of $243.45 million.
For earnings history and earnings-related data on Elizabeth Arden, Inc. (RDEN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- UPDATE: Aruba Networks, Inc. (ARUN) Misses Q3 EPS by 4c, Guidance Light
- Natus Medical (BABY) Tops Q1 EPS by 4c; Nudges FY13 EPS Outlook Higher
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

